Regulatory · source year

2012 regulatory records

6 selected, source-linked regulatory records dated 2012. This is selective source coverage, not a complete timeline.

Dated records

6 selected records.

Peptide profiles

6 connected profiles.

Cited sources

6 distinct public records.

Cited chronology

Dated source records

Open in the filterable feed →

September 2012

1 record

August 2012

1 record

May 2012

2 records

Tesamorelin

Federal Register notice 2012-10808

The Federal Register published notice 2012-10808, attributed to FDA and its parent HHS department, on 2012-05-04. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; EGRIFTA,” and PeptideScanner's exact reviewed identity mapping connects the document to Tesamorelin.

Source: Federal Register via GovInfo ↗

Liraglutide

Federal Register notice 2012-10517

The Federal Register published notice 2012-10517, attributed to FDA and its parent HHS department, on 2012-05-02. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; Victoza,” and PeptideScanner's exact reviewed identity mapping connects the document to Liraglutide.

Source: Federal Register via GovInfo ↗

January 2012

2 records

Leuprolide + 1 more

Federal Register notice 2012-1433

The Federal Register published notice 2012-1433, attributed to FDA and its parent HHS department, on 2012-01-25. Its official title is “Draft and Revised Draft Guidances for Industry Describing Product-Specific Bioequivalence Recommendations; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide and Octreotide.

Source: Federal Register via GovInfo ↗